OBJECTIVES: The aim of this study was to define which measure of microvascular best predicts the extent of left ventricular (LV) infarction. BACKGROUND: Microvascular injury after ST-segment elevation myocardial infarction (STEMI) is an important determinant of outcome. Several invasive measures of the microcirculation at primary percutaneous coronary intervention (PPCI) have been described. One such measure is zero-flow pressure (Pzf), the calculated pressure at which coronary flow would cease. METHODS: In 34 STEMI patients, Pzf, hyperemic microvascular resistance (hMR), and index of microcirculatory resistance (IMR) were derived using thermodilution flow/pressure and Doppler flow/pressure wire assessment of the infarct-related artery following PPCI. The extent of infarction was determined by blinded late gadolinium enhancement on cardiac magnetic resonance at 6 months post-PPCI. Infarction of ≥24% total LV mass was used as a categorical cutoff in receiver-operating characteristic curve analysis. RESULTS: Pzf was superior to both hMR and IMR for predicting ≥24% infarction area under the curve: 0.94 for Pzf versus 0.74 for hMR (p = 0.04) and 0.54 for IMR (p = 0.003). Pzf ≥42 mm Hg was the optimal cutoff value, offering 100% sensitivity and 73% specificity. Patients with Pzf ≥42 mm Hg also had a lower salvage index (61.3 ± 8.1 vs. 44.4 ± 16.8, p = 0.006) and 6-month ejection fraction (62.4 ± 3.6 vs. 49.9 ± 9.6, p = 0.002). In addition, there were significant direct relationships between Pzf and troponin area under the curve (rho = 0.55, p = 0.002), final infarct mass (rho = 0.75, p < 0.0001), percentage of LV infarction and percent transmurality of infarction (rho = 0.77 and 0.74, respectively, p < 0.0001), and inverse relationships with myocardial salvage index (rho = -0.53, p = 0.01) and 6-month ejection fraction (rho = -0.73, p = 0.0001). CONCLUSIONS: Pzf measured at the time of PPCI is a better predictor of the extent of myocardial infarction than hMR or IMR. Pzf may provide important prognostic information at the time of PPCI and merits further investigation in clinical studies with relevant outcome measures.
OBJECTIVES: The aim of this study was to define which measure of microvascular best predicts the extent of left ventricular (LV) infarction. BACKGROUND: Microvascular injury after ST-segment elevation myocardial infarction (STEMI) is an important determinant of outcome. Several invasive measures of the microcirculation at primary percutaneous coronary intervention (PPCI) have been described. One such measure is zero-flow pressure (Pzf), the calculated pressure at which coronary flow would cease. METHODS: In 34 STEMI patients, Pzf, hyperemic microvascular resistance (hMR), and index of microcirculatory resistance (IMR) were derived using thermodilution flow/pressure and Doppler flow/pressure wire assessment of the infarct-related artery following PPCI. The extent of infarction was determined by blinded late gadolinium enhancement on cardiac magnetic resonance at 6 months post-PPCI. Infarction of ≥24% total LV mass was used as a categorical cutoff in receiver-operating characteristic curve analysis. RESULTS: Pzf was superior to both hMR and IMR for predicting ≥24% infarction area under the curve: 0.94 for Pzf versus 0.74 for hMR (p = 0.04) and 0.54 for IMR (p = 0.003). Pzf ≥42 mm Hg was the optimal cutoff value, offering 100% sensitivity and 73% specificity. Patients with Pzf ≥42 mm Hg also had a lower salvage index (61.3 ± 8.1 vs. 44.4 ± 16.8, p = 0.006) and 6-month ejection fraction (62.4 ± 3.6 vs. 49.9 ± 9.6, p = 0.002). In addition, there were significant direct relationships between Pzf and troponin area under the curve (rho = 0.55, p = 0.002), final infarct mass (rho = 0.75, p < 0.0001), percentage of LV infarction and percent transmurality of infarction (rho = 0.77 and 0.74, respectively, p < 0.0001), and inverse relationships with myocardial salvage index (rho = -0.53, p = 0.01) and 6-month ejection fraction (rho = -0.73, p = 0.0001). CONCLUSIONS: Pzf measured at the time of PPCI is a better predictor of the extent of myocardial infarction than hMR or IMR. Pzf may provide important prognostic information at the time of PPCI and merits further investigation in clinical studies with relevant outcome measures.
Authors: Hernán Mejía-Rentería; Nina van der Hoeven; Tim P van de Hoef; Julius Heemelaar; Nicola Ryan; Amir Lerman; Niels van Royen; Javier Escaned Journal: Int J Cardiovasc Imaging Date: 2017-05-13 Impact factor: 2.357
Authors: Murat Sezer; Javier Escaned; Christopher J Broyd; Berrin Umman; Zehra Bugra; Ilke Ozcan; Mehmet Rasih Sonsoz; Alp Ozcan; Adem Atici; Emre Aslanger; Z Irem Sezer; Justin E Davies; Niels van Royen; Sabahattin Umman Journal: J Am Heart Assoc Date: 2022-05-16 Impact factor: 6.106
Authors: Matthias Kohlhauer; Sam Dawkins; Ana S H Costa; Regent Lee; Timothy Young; Victoria R Pell; Robin P Choudhury; Adrian P Banning; Rajesh K Kharbanda; Kourosh Saeb-Parsy; Michael P Murphy; Christian Frezza; Thomas Krieg; Keith M Channon Journal: J Am Heart Assoc Date: 2018-04-06 Impact factor: 5.501
Authors: Gregor Fahrni; Mathias Wolfrum; Giovanni Luigi De Maria; Florim Cuculi; Sam Dawkins; Mohammad Alkhalil; Niket Patel; John C Forfar; Bernard D Prendergast; Robin P Choudhury; Keith M Channon; Adrian P Banning; Rajesh K Kharbanda Journal: J Am Heart Assoc Date: 2017-11-07 Impact factor: 5.501
Authors: Rupert P Williams; Guus A de Waard; Kalpa De Silva; Matthew Lumley; Kaleab Asrress; Satpal Arri; Howard Ellis; Awais Mir; Brian Clapp; Amedeo Chiribiri; Sven Plein; Paul F Teunissen; Maurits R Hollander; Michael Marber; Simon Redwood; Niels van Royen; Divaka Perera Journal: Am J Cardiol Date: 2017-10-10 Impact factor: 2.778